MedPage Today 

(1/28, Walsh) reported, "New psoriasis treatment
guidelines 

from the National Psoriasis Foundation" have been published in the
January Archives of Dermatology. "The guidelines, which summarize the
benefits and drawbacks of systemic agents currently in use for
psoriasis, are an update of earlier recommendations developed in
Canada." The guidelines note that "conventional drugs such as
methotrexate and cyclosporine
often are effective, but have significant toxicities, including liver
problems with methotrexate and kidney problems with cyclosporine."
No comments:
Post a Comment